EE9600057A - Flaviini derivaadid viirusvastaste toimeainetena kasutamiseks - Google Patents

Flaviini derivaadid viirusvastaste toimeainetena kasutamiseks

Info

Publication number
EE9600057A
EE9600057A EE9600057A EE9600057A EE9600057A EE 9600057 A EE9600057 A EE 9600057A EE 9600057 A EE9600057 A EE 9600057A EE 9600057 A EE9600057 A EE 9600057A EE 9600057 A EE9600057 A EE 9600057A
Authority
EE
Estonia
Prior art keywords
antiviral agents
flavin derivatives
flavin
derivatives
antiviral
Prior art date
Application number
EE9600057A
Other languages
English (en)
Estonian (et)
Inventor
Ayuko Washington Odur
Original Assignee
Radopath Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Radopath Limited filed Critical Radopath Limited
Publication of EE9600057A publication Critical patent/EE9600057A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
EE9600057A 1993-10-19 1994-10-19 Flaviini derivaadid viirusvastaste toimeainetena kasutamiseks EE9600057A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939321558A GB9321558D0 (en) 1993-10-19 1993-10-19 Anti-viral agents
PCT/GB1994/002292 WO1995011028A1 (fr) 1993-10-19 1994-10-19 Derives de flavine utilises comme agents antiviraux

Publications (1)

Publication Number Publication Date
EE9600057A true EE9600057A (et) 1996-10-15

Family

ID=10743784

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9600057A EE9600057A (et) 1993-10-19 1994-10-19 Flaviini derivaadid viirusvastaste toimeainetena kasutamiseks

Country Status (26)

Country Link
EP (1) EP0739208A1 (fr)
JP (1) JPH09505804A (fr)
CN (1) CN1140992A (fr)
AP (1) AP620A (fr)
AU (1) AU7943794A (fr)
BG (1) BG100599A (fr)
BR (1) BR9407862A (fr)
CA (2) CA2123825A1 (fr)
CO (1) CO4520283A1 (fr)
CZ (1) CZ113796A3 (fr)
EE (1) EE9600057A (fr)
GB (2) GB9321558D0 (fr)
HR (1) HRP940688A2 (fr)
HU (1) HUT76322A (fr)
IL (1) IL111338A0 (fr)
JO (1) JO1866B1 (fr)
MA (1) MA23356A1 (fr)
MD (1) MD960168A (fr)
NO (1) NO961547L (fr)
OA (1) OA10579A (fr)
PE (1) PE5596A1 (fr)
PL (1) PL314008A1 (fr)
SK (1) SK50696A3 (fr)
UY (1) UY23844A1 (fr)
WO (1) WO1995011028A1 (fr)
ZA (1) ZA948191B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07188052A (ja) * 1993-12-27 1995-07-25 Sanwa Kagaku Kenkyusho Co Ltd インターフェロン用作用効果増強剤及び該増強剤とインターフェロンとを含有する抗ウイルス活性増強組成物
US5756479A (en) * 1994-12-29 1998-05-26 Research Development Foundation Flavin adenine dinucleotide analogue inhibitors of monoamine oxidase
US9044523B2 (en) 2000-06-15 2015-06-02 Terumo Bct, Inc. Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light
US6933285B2 (en) * 2002-05-10 2005-08-23 The Ohio State University Flavin N-oxides: new anti-cancer agents and pathogen eradication agents
ITTO20020622A1 (it) 2002-07-16 2004-01-16 Dayco Europe Srl Gruppo integrato puleggia-smorzatore torsionale
US20060293335A1 (en) * 2002-08-02 2006-12-28 Qishou Xu Riboflavin derivative and its manufacture and uses
EP2545788A1 (fr) * 2011-07-13 2013-01-16 Martin Hulliger Système diététique à plusieurs composants
JP2018131410A (ja) * 2017-02-15 2018-08-23 ヒノキ新薬株式会社 カスパーゼ−３阻害剤とその用途
US11497749B2 (en) * 2017-10-24 2022-11-15 Lunella Biotech, Inc. Mitoflavoscins: targeting flavin-containing enzymes eliminates cancer stem cells (CSCS) by inhibiting mitochondrial respiration
CN114126603A (zh) * 2019-07-09 2022-03-01 帝斯曼知识产权资产管理有限公司 用核黄素或dha降低艾拉弗德的病毒活性

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4219545A (en) * 1979-03-23 1980-08-26 Collins Calvin E Treatment of infectious keratoconjunctivitis in animals
US4264601A (en) * 1979-06-12 1981-04-28 The Board Of Regents Of The University Of Oklahoma Antihypertensive agents and their use in treatment of hypertension
US4500524A (en) * 1982-09-15 1985-02-19 Trustees Of Boston University Tranquilizing and reducing or preventing seizures
WO1991002529A2 (fr) * 1989-08-14 1991-03-07 John Bennett Kizer Produit et methode pour tuer les cellules anormales chez les vertebres
JP2727471B2 (ja) * 1989-09-14 1998-03-11 三井農林株式会社 インフルエンザウィルス感染予防剤
US5192264A (en) * 1989-10-06 1993-03-09 The Beth Israel Hospital Association Methods and apparatus for treating disease states using oxidized lipoproteins
US5217716A (en) * 1990-07-18 1993-06-08 The Beth Israel Hospital Association Method for treating viral infections using oxidized lipoproteins
FR2674753B1 (fr) * 1991-04-02 1995-03-10 Jean Berque Nouvelles indications therapeutiques, en particulier pour le traitement du sida, d'un medicament deja existant et fabrique a partir d'une molecule denuee de contre-indications et d'effets indesirables.
NZ244270A (en) * 1991-09-13 1995-07-26 Eisai Co Ltd Injectable composition comprising riboflavin
WO1993010784A1 (fr) * 1991-11-25 1993-06-10 University Of Michigan Composition et procede therapeutiques de prevention de lesions occasionnees par perfusion
JP3073309B2 (ja) * 1992-03-27 2000-08-07 雪印乳業株式会社 シアル酸結合５−デアザフラビン系化合物

Also Published As

Publication number Publication date
CN1140992A (zh) 1997-01-22
MD960168A (ro) 1998-04-30
HUT76322A (en) 1997-08-28
HU9601006D0 (en) 1996-06-28
NO961547D0 (no) 1996-04-18
PE5596A1 (es) 1996-04-18
GB9421099D0 (en) 1994-12-07
IL111338A0 (en) 1994-12-29
EP0739208A1 (fr) 1996-10-30
AP620A (en) 1997-10-14
SK50696A3 (en) 1997-01-08
CA2174552A1 (fr) 1995-04-27
CO4520283A1 (es) 1997-10-15
BR9407862A (pt) 1997-05-20
GB9321558D0 (en) 1993-12-08
ZA948191B (en) 1995-06-08
CZ113796A3 (en) 1996-11-13
BG100599A (en) 1997-02-28
JO1866B1 (en) 1995-12-27
HRP940688A2 (en) 1997-04-30
NO961547L (no) 1996-06-19
UY23844A1 (es) 1995-03-28
PL314008A1 (en) 1996-08-05
AU7943794A (en) 1995-05-08
JPH09505804A (ja) 1997-06-10
GB2283913A (en) 1995-05-24
AP9400695A0 (en) 1995-01-31
CA2123825A1 (fr) 1995-04-20
WO1995011028A1 (fr) 1995-04-27
OA10579A (en) 2002-06-19
MA23356A1 (fr) 1995-07-01

Similar Documents

Publication Publication Date Title
DE69325333T2 (de) Antivirale Zusammensetzung
EP0445098A3 (en) Deoxynojirimycin derivatives as antiviral agents
FI20021195A (fi) CDMA-taajuusallokointi
IT1271014B (it) 3-aril-benzofuranoni come agenti stabilizzanti
DE69433558D1 (de) Sende-Empfangsschaltungssystem
DE69330497D1 (de) Chinazolin-derivate
DE69325726T2 (de) Rettungswerkzeug
FI940167A0 (fi) Puriinijohdannaisia
FI913590A (fi) Kaivutyökalu
DE59308714D1 (de) Cyclobutan-benzol-derivate
FI955164A0 (fi) Heterosykliset johdannaiset
KR960703888A (ko) 이소플라본 유도체 (isoflavone derivatives)
NO952508D0 (no) Purinderivater
EE9600057A (et) Flaviini derivaadid viirusvastaste toimeainetena kasutamiseks
NO941135D0 (no) Tiazolpyrimidin derivater
DE59402621D1 (de) Fluor-trifluormethylbenzoesäure-Derivate
MX9204183A (es) Formulacion de prostagladina e1
FI972585A (fi) Virustenvastaisina aineina käyttökelpoiset tienoksatsinonijohdannaiset
DE69324199D1 (de) 4-Aminopyrrol-2-Carbonsäureamid-Derivate als antivirale Wirkstoffe
DE69425117D1 (de) Fluorierte Diazabicycloalkanderivate
DE69316018T2 (de) Carbostyrilderivate als antiarrhytmika
DE59407726D1 (de) 3-Aryl-4-hydroxy-3-dihydrofuranon-Derivate
EE9400040A (et) Oftalmiliseks otstarbeks mõeldud kompositsioon
NO950327D0 (no) Pyridoindolobenzodiazepiner og derivater som antipsykotiske midler
FI950101A0 (fi) 4-oksa-1-atsabisyklo 3,2,0 -7heptanoni-johdannaiset kasvainten vastaisina aineina